These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2084960)

  • 41. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.
    Jaspan JB; Sullivan K; Garry RF; Lopez M; Wolfe M; Clejan S; Yan C; Tenenbaum S; Sander DM; Ahmed B; Bryer-Ash M
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2271-9. PubMed ID: 8964863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fletcher factor deficiency in a 9-year-old girl: mechanisms of the contact pathway of blood coagulation.
    DeLa Cadena RA
    Am J Hematol; 1995 Apr; 48(4):273-7. PubMed ID: 7717377
    [No Abstract]   [Full Text] [Related]  

  • 43. Simultaneous occurrence of subacute thyroiditis and Graves' disease.
    Hoang TD; Mai VQ; Clyde PW; Shakir MK
    Thyroid; 2011 Dec; 21(12):1397-400. PubMed ID: 22136271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
    Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
    J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evans' syndrome associated with Graves' disease.
    Yashiro M; Nagoshi H; Kasuga Y; Isobe H; Kitajima S; Nakagawa T; Ohshima J; Ide K; Someya K; Saito N
    Intern Med; 1996 Dec; 35(12):987-90. PubMed ID: 9031001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stroke in a young adult with Fletcher trait.
    Hess DC; Krauss JS; Rardin D
    South Med J; 1991 Apr; 84(4):507-8. PubMed ID: 2014441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on the association of NIDDM in Japanese patients with hyperthyroid Graves' disease.
    Komiya I; Takasu N; Yamada T; Ohara N; Ootsuka H; Ota M; Fukushima H; Sekikawa A; Tominaga M; Sasaki H
    Horm Res; 1992; 38(5-6):264-8. PubMed ID: 1307749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fletcher factor deficiency in a woman requiring emergency caesarean section.
    Odumosu MC; Yoong WC; Fakokunde AF
    J Obstet Gynaecol; 2009 Jul; 29(5):442. PubMed ID: 19603330
    [No Abstract]   [Full Text] [Related]  

  • 49. Prekallikrein and plasminogen proactivator: absence of plasminogen proactivator in Fletcher factor deficient plasma.
    Venneröd AM; Laake K
    Thromb Res; 1976 Apr; 8(4):519-22. PubMed ID: 1273811
    [No Abstract]   [Full Text] [Related]  

  • 50. Isolated prolonged activated partial thromboplastin time in an asymptomatic patient: Fletcher factor deficiency.
    Acar K; Yağci M; Sucak GT; Haznedar R
    Thromb Res; 2006; 118(6):765-6. PubMed ID: 16414101
    [No Abstract]   [Full Text] [Related]  

  • 51. Onset of Graves' thyrotoxicosis after an attack of allergic rhinitis.
    Hidaka Y; Masai T; Sumizaki H; Takeoka K; Tada H; Amino N
    Thyroid; 1996 Aug; 6(4):349-51. PubMed ID: 8875759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severe plasma prekallikrein deficiency: Clinical characteristics, novel KLKB1 mutations, and estimated prevalence.
    Barco S; Sollfrank S; Trinchero A; Adenaeuer A; Abolghasemi H; Conti L; Häuser F; Kremer Hovinga JA; Lackner KJ; Loewecke F; Miloni E; Vazifeh Shiran N; Tomao L; Wuillemin WA; Zieger B; Lämmle B; Rossmann H
    J Thromb Haemost; 2020 Jul; 18(7):1598-1617. PubMed ID: 32202057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
    Iijima K; Arakawa Y; Sugahara Y; Matsushita M; Moriguchi Y; Shimohiro H; Nakagawa M
    Thromb Haemost; 2011 Mar; 105(3):473-8. PubMed ID: 21264442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factor XII and partial prekallikrein deficiencies in a dog with recurrent gastrointestinal hemorrhage.
    Otto CM; Dodds WJ; Greene CE
    J Am Vet Med Assoc; 1991 Jan; 198(1):129-31. PubMed ID: 1995570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA.
    Farid NR; Barnard JM; Marshall WH; Woolfrey I; O'Driscoll RF
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1165-72. PubMed ID: 579351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP; Gozin D
    Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Replacement therapy in a patient with congenital prekallikrein deficiency undergoing surgery.
    Shigekiyo T; Fujino O
    Int J Hematol; 1992 Aug; 56(1):89-93. PubMed ID: 1391808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IGF1 deficiency in newly diagnosed Graves' disease patients.
    Martin S; Sirbu A; Betivoiu M; Florea S; Barbu C; Fica S
    Hormones (Athens); 2015; 14(4):651-9. PubMed ID: 26188228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Graves' disease in patients with 22q11.2 deletion.
    Kawame H; Adachi M; Tachibana K; Kurosawa K; Ito F; Gleason MM; Weinzimer S; Levitt-Katz L; Sullivan K; McDonald-McGinn DM
    J Pediatr; 2001 Dec; 139(6):892-5. PubMed ID: 11743521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familial risks for hospitalized Graves' disease and goiter.
    Hemminki K; Shu X; Li X; Ji J; Sundquist K; Sundquist J
    Eur J Endocrinol; 2009 Oct; 161(4):623-9. PubMed ID: 19661127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.